chr5-151020710-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_002084.5(GPX3):c.56T>A(p.Val19Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000862 in 1,611,608 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_002084.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPX3 | NM_002084.5 | c.56T>A | p.Val19Asp | missense_variant | 1/5 | ENST00000388825.9 | NP_002075.2 | |
GPX3 | NM_001329790.2 | c.56T>A | p.Val19Asp | missense_variant | 1/6 | NP_001316719.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPX3 | ENST00000388825.9 | c.56T>A | p.Val19Asp | missense_variant | 1/5 | 1 | NM_002084.5 | ENSP00000373477.4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152126Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000288 AC: 7AN: 242684Hom.: 0 AF XY: 0.0000301 AC XY: 4AN XY: 132958
GnomAD4 exome AF: 0.0000884 AC: 129AN: 1459482Hom.: 0 Cov.: 31 AF XY: 0.0000771 AC XY: 56AN XY: 726034
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152126Hom.: 0 Cov.: 33 AF XY: 0.0000538 AC XY: 4AN XY: 74316
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 06, 2022 | The c.56T>A (p.V19D) alteration is located in exon 1 (coding exon 1) of the GPX3 gene. This alteration results from a T to A substitution at nucleotide position 56, causing the valine (V) at amino acid position 19 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at